Fmoc-Gly-OH-1-13C | Axygen爱思进官网

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物，专注于信号通路和疾病研究领域。
Fmoc-Gly-OH-1-13C

Fmoc-Gly-OH-1-13C 是一种 13C 标记的 Carbendazim。Carbendazim 是一种有效的，具有口服活性的口服广谱苯并咪唑杀菌剂 (fungicide)，可作为真菌疾病研究的杀虫剂，如孢霉病、镰刀菌病和菌核病。Carbendazim 是一种具有抗肿瘤活性的苯并咪唑 (HY-Y1825) 衍生物，用于癌症研究，特别是晚期实体肿瘤和淋巴瘤。

Fmoc-Gly-OH-1-13C Chemical Structure

CAS No. : 197965-68-7

规格		是否有货
100 mg		询价
250 mg		询价
500 mg		询价

* Please select Quantity before adding items.

生物活性	Fmoc-Gly-OH-1-13C is a 13C-labeled Carbendazim. Carbendazim is a potent and orally active broad-spectrum benzimidazole fungicide and can be acts as a pesticide for fungal diseases research, such as Seproria, Fusarium and Sclerotina[1][3]. Carbendazim is a
体外研究 (In Vitro)	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[75]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量	298.30
Formula	C₁₆¹³CH₁₅NO₄
CAS 号	197965-68-7
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-228. [2]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-228.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务